摘要
目的分析蚌埠市第一人民医院急性心肌梗死近20年药物治疗的变化,探讨急性心肌梗死药物治疗进展。方法分别统计该院1989年1月-1999年12月402例(A组)急性心肌梗死和2000年1月-2010年12月414例(B组)急性心肌梗死的常规药物治疗比例和疗效,探讨急性心肌梗死药物治疗进展。结果 A组402例,应用阿司匹林380例,使用率为94.5%,应用肝素或低分子肝素262例,使用率为65.2%,β-受体阻滞剂美托洛尔应用132例,使用率为57.7%,应用他汀类药物240例,使用率为59.7%,B组应用阿司匹林412例,使用率为99.5%,应用肝素或低分子肝素408例,使用率为98.6%,应用β-受体阻滞剂美托洛尔302例,使用率为72.9%,应用他汀类药物396例,使用率为95.7%。B组住院天数减少,院内并发症死亡率降低。结论最近10年阿司匹林、肝素或低分子肝素、β-受体阻滞剂美托洛尔、他汀类药物使用率明显升高,提示该院急性心肌梗死的药物治疗水平也在明显提高。
Objective To observe medication changes of acute myocardial infarction nearly twenty years in Bengbu NO1 hospital,and to explore acute myocardial infarction drug therapy.Methods 402 cases of acute myocardial infarction（group A） were from January 1989 to December 1999,and 414 cases（group B） of acute myocardial infarction were from January 2000 to December 2010,the routine drug therapy proportion and the efficacy were analyzed to explore acute myocardial infarction drug therapy.Statistics was conducted.Results 380 among 402 cases in group A were treated with aspirin in,with the usage rate of 94.5%;the use of heparin or low molecular weight heparin in 262 patients,with the rate of 65.2%,the use of β-receptor blocker metoprolol in 132 cases,with the rate of 57.7%,the use of statin drugs in 240 cases,with the rate of 59.7%.412 cases in group B were treated with aspirin in,with usage rate of 99.5%,the use of heparin or low molecular weight heparin in 408 patients,with usage rate of 98.6%,the use of β-receptor blocker metoprolol in 302 cases,with usage rate of 72.9%,the use of statin drugs in 396 cases,with usage rate of 95.7%.Decreased length of stay and reduction of hospital mortality associated with syndrome were observed in group B.Conclusion In recent ten years,aspirin,heparin or low molecular weight heparin,β-receptor blocker metoprolol,and statin usage rate was apparently increased,which indicated that the drug therapy of acute myocardial infarction was markedly improved.
出处
《中华全科医学》
2012年第5期718-718,720,共2页
Chinese Journal of General Practice
